Vergne L - Search Results

1

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study.

Laurent C, Diakhaté N, Gueye NF, Touré MA, Sow PS, Faye MA, Gueye M, Lanièce I, Touré Kane C, Liégeois F, Vergne L, Mboup S, Badiane S, Ndoye I, Delaporte E. Laurent C, et al. Among authors: vergne l. AIDS. 2002 Jul 5;16(10):1363-70. doi: 10.1097/00002030-200207050-00008. AIDS. 2002. PMID: 12131213 Clinical Trial.

2

Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.

Vergne L, Kane CT, Laurent C, Diakhaté N, Gueye NF, Gueye PM, Sow PS, Faye MA, Liégeois F, Ndir A, Lanièce I, Peeters M, Ndoye I, Mboup S, Delaporte E. Vergne L, et al. AIDS. 2003 Jul;17 Suppl 3:S31-8. doi: 10.1097/00002030-200317003-00005. AIDS. 2003. PMID: 14565607

3

Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults.

Laurent C, Ngom Gueye NF, Ndour CT, Gueye PM, Diouf M, Diakhaté N, Touré Kane NC, Lanièce I, Ndir A, Vergne L, Ndoye I, Mboup S, Sow PS, Delaporte E; ANRS 1215/1290 Study Group. Laurent C, et al. Among authors: vergne l. J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):14-7. doi: 10.1097/00126334-200501010-00003. J Acquir Immune Defic Syndr. 2005. PMID: 15608518

4

Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage.

Vergne L, Bourgeois A, Mpoudi-Ngole E, Mougnutou R, Mbuagbaw J, Liegeois F, Laurent C, Butel C, Zekeng L, Delaporte E, Peeters M. Vergne L, et al. Virology. 2003 Jun 5;310(2):254-66. doi: 10.1016/s0042-6822(03)00167-3. Virology. 2003. PMID: 12781713 Free article.

5

Antiretroviral drug resistance and routine therapy, Cameroon.

Laurent C, Kouanfack C, Vergne L, Tardy M, Zekeng L, Noumsi N, Butel C, Bourgeois A, Mpoudi-Ngolé E, Koulla-Shiro S, Peeters M, Delaporte E. Laurent C, et al. Among authors: vergne l. Emerg Infect Dis. 2006 Jun;12(6):1001-4. doi: 10.3201/eid1206.050860. Emerg Infect Dis. 2006. PMID: 16707062 Free PMC article.

6

HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon.

Vergne L, Diagbouga S, Kouanfack C, Aghokeng A, Butel C, Laurent C, Noumssi N, Tardy M, Sawadogo A, Drabo J, Hien H, Zekeng L, Delaporte E, Peeters M. Vergne L, et al. Antivir Ther. 2006;11(5):575-9. Antivir Ther. 2006. PMID: 16964825

7

Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine.

Laurent C, Kouanfack C, Koulla-Shiro S, Njoume M, Nkene YM, Ciaffi L, Brulet C, Peytavin G, Vergne L, Calmy A, Mpoudi-Ngolé E, Delaporte E. Laurent C, et al. Among authors: vergne l. AIDS. 2007 Mar 30;21(6):768-71. doi: 10.1097/QAD.0b013e328045c4d7. AIDS. 2007. PMID: 17413701 Clinical Trial.

8

Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries.

Vergne L, Malonga-Mouellet G, Mistoul I, Mavoungou R, Mansaray H, Peeters M, Delaporte E. Vergne L, et al. J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):165-8. doi: 10.1097/00042560-200202010-00009. J Acquir Immune Defic Syndr. 2002. PMID: 11832686

9

Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B.

Montes B, Vergne L, Peeters M, Reynes J, Delaporte E, Segondy M. Montes B, et al. Among authors: vergne l. J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):329-36. doi: 10.1097/00126334-200404010-00001. J Acquir Immune Defic Syndr. 2004. PMID: 15097148

10

Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.

Vergne L, Stuyver L, Van Houtte M, Butel C, Delaporte E, Peeters M. Vergne L, et al. J Clin Virol. 2006 May;36(1):43-9. doi: 10.1016/j.jcv.2006.01.012. Epub 2006 Mar 24. J Clin Virol. 2006. PMID: 16563858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page